Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). [electronic resource]
Producer: 20100824Description: 1020-30 p. digitalISSN:- 1523-1755
- Acute Disease
- Aged
- Alkaline Phosphatase -- urine
- Biomarkers -- blood
- Creatinine -- blood
- Double-Blind Method
- Drug Administration Schedule
- Erythropoietin -- administration & dosage
- Female
- Hematinics -- administration & dosage
- Humans
- Intensive Care Units
- Kidney Diseases -- etiology
- Male
- Middle Aged
- New Zealand
- Patient Selection
- Placebo Effect
- Predictive Value of Tests
- Prospective Studies
- Risk Assessment
- Risk Factors
- Time Factors
- Treatment Outcome
- Triage
- gamma-Glutamyltransferase -- urine
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.